Picture of Genetic Technologies logo

GTG Genetic Technologies Cashflow Statement

0.000.00%
au flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Genetic Technologies, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

2020
June 30th
2021
June 30th
2022
June 30th
2023
June 30th
2024
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSPRESS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinalFinal
Changes in Working Capital1.041.332.41.961.75
Other Operating Cash Flow
Cash from Operating Activities-5.71-6.3-5.66-9.72-9.68
Capital Expenditures-0.038-0.749-0.097-0.018-0.033
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.1030-3.36-0.2940.148
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities0.065-0.749-3.46-0.3120.115
Financing Cash Flow Items-3.3-1.97-0.01-0.916-0.007
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities18.413.7-0.2795.922.82
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash12.16.69-9.17-3.88-6.83